Filings

6 documents · 39 matches

1. SPRO Spero Therapeutics, Inc. 10-Q 2025-05-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   Going Concern (Subtopic 205-40), we are required to evaluate whether there are conditions and events, considered in the aggregate
   9 matches in this document Show context Copy citation

2. SPRO Spero Therapeutics, Inc. 10-Q 2026-08-12

   Item 1A. Risk Factors.

   Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
   6 matches in this document Show context Copy citation

3. SPRO Spero Therapeutics, Inc. 10-Q 2026-05-13

   Item 1A. Risk Factors.

   Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
   6 matches in this document Show context Copy citation

4. SPRO Spero Therapeutics, Inc. 10-K 2026-03-26

   Item 1A. Risk Factors.

   Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
   6 matches in this document Show context Copy citation

5. SPRO Spero Therapeutics, Inc. 10-Q 2025-11-13

   Item 1A. Risk Factors.

   Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
   6 matches in this document Show context Copy citation

6. SPRO Spero Therapeutics, Inc. 10-Q 2025-08-12

   Item 1A. Risk Factors.

   Going Concern (Subtopic 205- 40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise
   6 matches in this document Show context Copy citation